459

Compound name
Upadacitinib
Alt Name
ABT-494
Rinvoq
Compound Image
Upadacitinib.png
SMILES
CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F
MW
380.40
Brutto
C17H19F3N6O
InChI
InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1
InChI Key
WYQFJHHDOKWSHR-MNOVXSKESA-N
Approval Jurisdiction
2019 FDA 2019 EMA
Approved for clinical use
Rheumatoid Arthritis
CAS
1310726-60-3
PubChem CID
58557659
Action
JAK1
Approved Drug List
1
Commercial Vendor
AbbVie